Fintel reports that on January 5, 2024, UBS initiated coverage of Envista Holdings (NYSE:NVST) with a Neutral recommendation.
Analyst Price Forecast Suggests 28.46% Upside
As of December 15, 2023, the average one-year price target for Envista Holdings is 30.03. The forecasts range from a low of 22.22 to a high of $39.90. The average price target represents an increase of 28.46% from its latest reported closing price of 23.38.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Envista Holdings is 2,937MM, an increase of 13.76%. The projected annual non-GAAP EPS is 2.34.
What is the Fund Sentiment?
There are 781 funds or institutions reporting positions in Envista Holdings. This is an increase of 19 owner(s) or 2.49% in the last quarter. Average portfolio weight of all funds dedicated to NVST is 0.28%, a decrease of 8.87%. Total shares owned by institutions decreased in the last three months by 2.32% to 224,300K shares. 
The put/call ratio of NVST is 0.40, indicating a bullish outlook.
What are Other Shareholders Doing?
Harris Associates L P holds 9,011K shares representing 5.26% ownership of the company. In it's prior filing, the firm reported owning 6,203K shares, representing an increase of 31.17%. The firm increased its portfolio allocation in NVST by 23.73% over the last quarter.
EAASX - Eaton Vance Atlanta Capital SMID-Cap Fund holds 8,101K shares representing 4.73% ownership of the company. No change in the last quarter.
Lazard Asset Management holds 7,557K shares representing 4.41% ownership of the company. In it's prior filing, the firm reported owning 7,384K shares, representing an increase of 2.29%. The firm decreased its portfolio allocation in NVST by 6.82% over the last quarter.
Massachusetts Financial Services holds 6,928K shares representing 4.04% ownership of the company. In it's prior filing, the firm reported owning 8,294K shares, representing a decrease of 19.72%. The firm decreased its portfolio allocation in NVST by 26.83% over the last quarter.
Gates Capital Management holds 5,664K shares representing 3.30% ownership of the company. In it's prior filing, the firm reported owning 2,713K shares, representing an increase of 52.10%. The firm increased its portfolio allocation in NVST by 83.00% over the last quarter.
Envista Holdings Background Information
(This description is provided by the company.)
Envista is a global family of more than 30 trusted dental brands, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers an estimated 90% of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. Envista companies, including KaVo Kerr, Nobel Biocare, and Ormco, partner with dental professionals to help them deliver the best possible patient care. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
